Head to Head Comparison: Innovative Eyewear (NASDAQ:LUCY) versus ICU Medical (NASDAQ:ICUI)

Innovative Eyewear (NASDAQ:LUCY – Get Free Report) and ICU Medical (NASDAQ:ICUI – Get Free Report) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, dividends, earnings, valuation, profitability, risk and institutional ownership.

Profitability

This table compares Innovative Eyewear and ICU Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Innovative Eyewear -216.76% -102.66% -92.20%
ICU Medical 2.76% 8.40% 4.51%

Valuation & Earnings

This table compares Innovative Eyewear and ICU Medical”s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Innovative Eyewear $2.66 million 2.65 -$7.59 million ($1.18) -0.69
ICU Medical $2.23 billion 2.01 $730,000.00 $2.39 75.01

ICU Medical has higher revenue and earnings than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than ICU Medical, indicating that it is currently the more affordable of the two stocks.

Insider & Institutional Ownership

1.0% of Innovative Eyewear shares are held by institutional investors. Comparatively, 96.1% of ICU Medical shares are held by institutional investors. 1.8% of Innovative Eyewear shares are held by insiders. Comparatively, 2.1% of ICU Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Volatility and Risk

Innovative Eyewear has a beta of 2.75, meaning that its stock price is 175% more volatile than the S&P 500. Comparatively, ICU Medical has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings for Innovative Eyewear and ICU Medical, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear 1 1 0 0 1.50
ICU Medical 0 3 4 2 2.89

ICU Medical has a consensus target price of $195.20, indicating a potential upside of 8.89%. Given ICU Medical’s stronger consensus rating and higher probable upside, analysts clearly believe ICU Medical is more favorable than Innovative Eyewear.

Summary

ICU Medical beats Innovative Eyewear on 12 of the 14 factors compared between the two stocks.

About Innovative Eyewear

(Get Free Report)

Innovative Eyewear, Inc. is a technology and eyewear company that develops and sells smart glasses designed to combine traditional eyewear with wireless audio and hands-free digital functionality. Its products generally incorporate speakers, microphones and Bluetooth connectivity, allowing users to listen to music, make calls and interact with voice assistants while keeping their hands free. The company markets products under the Lucyd brand, including prescription-capable eyewear, sunglasses and blue-light-filtering styles.

About ICU Medical

(Get Free Report)

ICU Medical is a medical technology company that develops, manufactures and markets products used in infusion therapy, vascular access and critical care. Its offerings include infusion pumps and related sets and accessories, IV solutions, needlefree connectors, and products designed to help protect healthcare workers when handling hazardous drugs. Founded in 1984, the company expanded its product portfolio through acquisitions, including the infusion systems business of Hospira in 2017 and Smiths Medical in 2022.

Receive News & Ratings for Innovative Eyewear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovative Eyewear and related companies with MarketBeat.com's FREE daily email newsletter.